Physician profile
Katy Cool
NPI 1972201580
$5,648.11
in general payments reported to CMS, 2019-2025
35 companies · $3,009 in 2025
The $3,009 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,245 · 2024: $1,395 · 2025: $3,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,793 · Travel and Lodging: $1,198 · Education: $626 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,792.91 |
| Travel and Lodging | $1,198.21 |
| Education | $625.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,637.08 | 2025 | Axonics |
| Astellas Pharma US INC | $836.20 | 2023-2025 | Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $692.06 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $229.64 | 2023-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $207.65 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $194.73 | 2023-2024 | Pylarify |
| 180 Medical, INC. | $189.57 | 2023-2024 | Gentlecath, Gentlecath Glide |
| Dendreon Pharmaceuticals LLC | $182.70 | 2023-2024 | Provenge |
| Urogen Pharma, INC. | $171.34 | 2023-2025 | Jelmyto |
| Accord Healthcare, INC. | $157.74 | 2023-2025 | |
| Teleflex LLC | $151.37 | 2023-2025 | Urolift, Barrigel |
| Pfizer INC. | $120.44 | 2023-2024 | |
| Seagen INC. | $84.99 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $79.04 | 2023 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $62.38 | 2023-2024 | Xiaflex, Aveed |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $59.05 | 2025 | Tlando, Trelstar |
| Halozyme INC | $51.13 | 2023 | |
| Axonics, INC. | $50.38 | 2023-2024 | Axonics |
| Merck Sharp & Dohme LLC | $49.56 | 2023-2024 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $43.14 | 2025 | |
| Endo USA, INC. | $42.81 | 2024-2025 | Xiaflex, Aveed |
| Tolmar, INC. | $38.06 | 2023-2025 | Jatenzo, Eligard |
| Astrazeneca Pharmaceuticals LP | $36.35 | 2024-2025 | Lynparza |
| Immunitybio, INC. | $36.09 | 2024-2025 | |
| Olympus America INC. | $32.60 | 2024 | Itind System |
| Antares Pharma, INC. | $31.80 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Abc Home Medical Supply, INC. | $30.59 | 2024 | |
| Sun Pharmaceutical Industries INC. | $22.52 | 2023 | Yonsa |
| Abbvie INC. | $21.40 | 2025 | |
| Medtronic, INC. | $20.88 | 2025 | Altaviva |
| Coloplast Corp | $18.58 | 2025 | |
| Ferring Pharmaceuticals INC. | $17.93 | 2024 | Adstiladrin |
| Becton, Dickinson and Company | $17.52 | 2024 | Bd Phaseal |
| Dentsply Ih Ab | $17.29 | 2023 | Lofric |
| Kowa Pharmaceuticals America, INC. | $13.50 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katy Cool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.